Miroslav Levý
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
Papers in
-
- RNA modifications and cancer 6
- DNA Repair Mechanisms 5
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 9
- Cancer Genomics and Diagnostics 8
- Co-authors
- Pavel Vodička (33 shared papers)Ludmila Lipská (15 shared papers)Ľudmila Vodičková (21 shared papers)Alessio Naccarati (20 shared papers)Václav Liška (17 shared papers)Jana Slyšková (10 shared papers)Barbara Pardini (18 shared papers)Michaela Schneiderová (9 shared papers)
In The Last Decade
Miroslav Levý
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 665
- Oncology 337
- Pathology and Forensic Medicine 208
- Molecular Biology 758
- Pulmonary and Respiratory Medicine 144
Countries citing papers authored by Miroslav Levý
This map shows the geographic impact of Miroslav Levý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miroslav Levý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miroslav Levý more than expected).
Fields of papers citing papers by Miroslav Levý
This network shows the impact of papers produced by Miroslav Levý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miroslav Levý. The network helps show where Miroslav Levý may publish in the future.
Co-authors
The 25 scholars most cited alongside Miroslav Levý, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 220 | |
| 2 | 2012 | 89 | |
| 3 | 2015 | 80 | |
| 4 | 2012 | 62 | |
| 5 | 2012 | 54 | |
| 6 | Tumor markers in staging and prognosis of colorectal carcinoma. | 2008 | 54 |
| 7 | 2019 | 47 | |
| 8 | 2013 | 46 | |
| 9 | 2012 | 38 | |
| 10 | 2015 | 37 | |
| 11 | 2018 | 32 | |
| 12 | 2014 | 31 | |
| 13 | 2018 | 27 | |
| 14 | 2019 | 24 | |
| 15 | 2018 | 23 | |
| 16 | 2016 | 22 | |
| 17 | 2018 | 21 | |
| 18 | Parameters of biological activity in colorectal cancer. | 2011 | 21 |
| 19 | Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients. | 2012 | 20 |
| 20 | 2016 | 20 |
About Miroslav Levý
Miroslav Levý is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Surgery, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (17 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (9 papers), Cancer Genomics and Diagnostics (8 papers), RNA modifications and cancer (6 papers), Colorectal Cancer Screening and Detection (6 papers) and DNA Repair Mechanisms (5 papers). The work is most often cited by research in Cancer Research (665 citations), Oncology (337 citations), Pathology and Forensic Medicine (208 citations), Molecular Biology (758 citations) and Pulmonary and Respiratory Medicine (144 citations). Miroslav Levý has collaborated with scholars based in Czechia, Italy and Germany. Frequent co-authors include Pavel Vodička, Ludmila Lipská, Ľudmila Vodičková, Alessio Naccarati, Václav Liška, Jana Slyšková, Barbara Pardini, Michaela Schneiderová, Veronika Vymetálková and Tomáš Büchler. Their work appears in journals such as Mutagenesis, Carcinogenesis, Frontiers in Oncology, Clinical Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.